Haleon plc

LSE HLN.L

Haleon plc Free Cash Flow Yield on January 14, 2025: 5.54%

Haleon plc Free Cash Flow Yield is 5.54% on January 14, 2025, a -4.50% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Haleon plc 52-week high Free Cash Flow Yield is 6.51% on December 20, 2024, which is 17.61% above the current Free Cash Flow Yield.
  • Haleon plc 52-week low Free Cash Flow Yield is 4.66% on September 27, 2024, which is -15.87% below the current Free Cash Flow Yield.
  • Haleon plc average Free Cash Flow Yield for the last 52 weeks is 5.56%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
LSE: HLN.L

Haleon plc

CEO Mr. Brian James McNamara
IPO Date July 18, 2022
Location United Kingdom
Headquarters Building 5
Employees 25,408
Sector Health Care
Industries
Description

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Similar companies

RKT.L

Reckitt Benckiser Group plc

USD 59.37

-0.51%

MNG.L

M&G plc

USD 2.36

1.48%

LGEN.L

Legal & General Group Plc

USD 2.73

1.22%

GSK.L

GSK plc

USD 15.79

-2.73%

StockViz Staff

January 15, 2025

Any question? Send us an email